全文获取类型
收费全文 | 56277篇 |
免费 | 4707篇 |
国内免费 | 49篇 |
专业分类
61033篇 |
出版年
2023年 | 200篇 |
2022年 | 584篇 |
2021年 | 1005篇 |
2020年 | 556篇 |
2019年 | 741篇 |
2018年 | 1133篇 |
2017年 | 889篇 |
2016年 | 1568篇 |
2015年 | 2585篇 |
2014年 | 2877篇 |
2013年 | 3371篇 |
2012年 | 4343篇 |
2011年 | 4154篇 |
2010年 | 2644篇 |
2009年 | 2321篇 |
2008年 | 3339篇 |
2007年 | 3100篇 |
2006年 | 2833篇 |
2005年 | 2559篇 |
2004年 | 2502篇 |
2003年 | 2226篇 |
2002年 | 1897篇 |
2001年 | 1645篇 |
2000年 | 1536篇 |
1999年 | 1218篇 |
1998年 | 529篇 |
1997年 | 469篇 |
1996年 | 401篇 |
1995年 | 393篇 |
1994年 | 306篇 |
1993年 | 298篇 |
1992年 | 640篇 |
1991年 | 516篇 |
1990年 | 474篇 |
1989年 | 479篇 |
1988年 | 406篇 |
1987年 | 390篇 |
1986年 | 318篇 |
1985年 | 329篇 |
1984年 | 270篇 |
1983年 | 224篇 |
1982年 | 190篇 |
1981年 | 162篇 |
1980年 | 160篇 |
1979年 | 220篇 |
1978年 | 197篇 |
1977年 | 179篇 |
1976年 | 171篇 |
1974年 | 197篇 |
1972年 | 155篇 |
排序方式: 共有10000条查询结果,搜索用时 15 毫秒
971.
972.
After an extensive vaccination policy, Japanese encephalitis (JE) was nearly eliminated since the mid-1980s in South Korea. Vaccination in children shifted the affected age of JE patients from children to adults. However, an abrupt increase in JE cases occurred in 2010, and this trend has continued. The present study aimed to investigate the prevalence of neutralizing antibodies to the JE virus (JEV) among high-risk age groups (≥40 years) in South Korea. A plaque reduction neutralization test was conducted to evaluate the prevalence of neutralizing antibodies to JEV in 945 subjects within four age groups (30–39, 40–49, 50–59, and 60–69 years) in 10 provinces. Of the 945 enrolled subjects, 927 (98.1%) exhibited antibodies against JEV. No significant differences were found in the prevalence of neutralizing antibodies according to sex, age, or occupation. However, there were significant differences in the plaque reduction rate according to age and occupation; oldest age group had a higher reduction rate, and subjects who were employed in agriculture or forestry also had a higher value than the other occupations. We also found that three provinces (Gangwon, Jeonnam, and Gyeongnam) had a relatively lower plaque reduction rate than the other locations. In addition, enzyme-linked immunosorbent assays were conducted to determine recent viral infections and 12 (2.2%) subjects were found to have been recently infected by the virus. In conclusion, the present study clearly indicated that the prevalence of neutralizing antibodies has been maintained at very high levels among adult age groups owing to vaccination or natural infections, or both. In the future, serosurveillance should be conducted periodically using more representative samples to better understand the population-level immunity to JE in South Korea. 相似文献
973.
974.
975.
Hsueh-Tzu Shih Wei-Yu Chen Kwei-Yan Liu Zong-Siou Shih Yi-Jyun Chen Paul-Chen Hsieh Kuan-Lin Kuo Kuo-How Huang Pang-Hung Hsu Ya-Wen Liu Shih-Peng Chan Hsiu-Hsiang Lee Yu-Chen Tsai June-Tai Wu 《PLoS genetics》2016,12(9)
To maintain a particular cell fate, a unique set of genes should be expressed while another set is repressed. One way to repress gene expression is through Polycomb group (PcG) proteins that compact chromatin into a silent configuration. In addition to cell fate maintenance, PcG proteins also maintain normal cell physiology, for example cell cycle. In the absence of PcG, ectopic activation of the PcG-repressed genes leads to developmental defects and malignant tumors. Little is known about the molecular nature of ectopic gene expression; especially what differentiates expression of a given gene in the orthotopic tissue (orthotopic expression) and the ectopic expression of the same gene due to PcG mutations. Here we present that ectopic gene expression in PcG mutant cells specifically requires dBRWD3, a negative regulator of HIRA/Yemanuclein (YEM)-mediated histone variant H3.3 deposition. dBRWD3 mutations suppress both the ectopic gene expression and aberrant tissue overgrowth in PcG mutants through a YEM-dependent mechanism. Our findings identified dBRWD3 as a critical regulator that is uniquely required for ectopic gene expression and aberrant tissue overgrowth caused by PcG mutations. 相似文献
976.
Sushil Bhandari Joon No Lee Young-Il Kim In-Koo Nam Su-Jung Kim Se-Jin Kim 《Organogenesis》2016,12(2):78-93
Very long chain fatty acids are required for sphingolipid synthesis, lipid homeostasis, myelin formation, epidermal permeability, and retinal function. Seven different enzymes are known to be involved in the elongation cycle of fatty acids, with different chain-length specificities. Elovl1 is one of those enzymes whose function has been linked mainly to the synthesis of sphingolipids and the epidermal barrier. However, the role of Elovl1 in organogenesis is not clear. In zebrafish, 2 Elovl1 genes, elovl1a and elovl1b, are highly expressed in the swim bladder, and elovl1b is also expressed in the kidney. We found that both elovl1 knockdown embryos contain increased levels of long chain fatty acids from carbon number 14 to 20 as compared to control embryos. Oil-Red-O staining shows that yolk lipid consumption is greatly reduced, whereas lipid droplets accumulate within the swim bladder. Notably, knockdown of either elovl1a or elovl1b affects the expression of genes involved in swim bladder development and impairs inflation of the swim bladder. Consistent with its expression in the pronephros, knockdown of elovl1b alone affects the expression of genes required for kidney development and reduces renal clearance. Our findings strongly suggest that both elovl1 genes are a key determinant of swim bladder and kidney development in zebrafish, which may be comparatively applicable to lung and kidney development in humans. 相似文献
977.
Lawrence J. Tartaglia Hui-Wen Chang Benjamin C. Lee Peter Abbink David Ng’ang’a Michael Boyd Christy L. Lavine So-Yon Lim Srisowmya Sanisetty James B. Whitney Michael S. Seaman Morgane Rolland Sodsai Tovanabutra Jintanat Ananworanich Merlin L. Robb Jerome H. Kim Nelson L. Michael Dan H. Barouch 《PLoS pathogens》2016,12(2)
Simian-human immunodeficiency virus (SHIV) challenge stocks are critical for preclinical testing of vaccines, antibodies, and other interventions aimed to prevent HIV-1. A major unmet need for the field has been the lack of a SHIV challenge stock expressing circulating recombinant form 01_AE (CRF01_AE) env sequences. We therefore sought to develop mucosally transmissible SHIV challenge stocks containing HIV-1 CRF01_AE env derived from acutely HIV-1 infected individuals from Thailand. SHIV-AE6, SHIV-AE6RM, and SHIV-AE16 contained env sequences that were >99% identical to the original HIV-1 isolate and did not require in vivo passaging. These viruses exhibited CCR5 tropism and displayed a tier 2 neutralization phenotype. These challenge stocks efficiently infected rhesus monkeys by the intrarectal route, replicated to high levels during acute infection, and established chronic viremia in a subset of animals. SHIV-AE16 was titrated for use in single, high dose as well as repetitive, low dose intrarectal challenge studies. These SHIV challenge stocks should facilitate the preclinical evaluation of vaccines, monoclonal antibodies, and other interventions targeted at preventing HIV-1 CRF01_AE infection. 相似文献
978.
Background
With evaluation for physical performance, measuring muscle mass is an important step in detecting sarcopenia. However, there are no methods to estimate muscle mass from blood sampling.Methods
To develop a new equation to estimate total-body muscle mass with serum creatinine and cystatin C level, we designed a cross-sectional study with separate derivation and validation cohorts. Total body muscle mass and fat mass were measured using dual-energy x-ray absorptiometry (DXA) in 214 adults aged 25 to 84 years who underwent physical checkups from 2010 to 2013 in a single tertiary hospital. Serum creatinine and cystatin C levels were also examined.Results
Serum creatinine was correlated with muscle mass (P < .001), and serum cystatin C was correlated with body fat mass (P < .001) after adjusting glomerular filtration rate (GFR). After eliminating GFR, an equation to estimate total-body muscle mass was generated and coefficients were calculated in the derivation cohort. There was an agreement between muscle mass calculated by the novel equation and measured by DXA in both the derivation and validation cohort (P < .001, adjusted R2 = 0.829, β = 0.95, P < .001, adjusted R2 = 0.856, β = 1.03, respectively).Conclusion
The new equation based on serum creatinine and cystatin C levels can be used to estimate total-body muscle mass. 相似文献979.
Cheng-Siang Lee Nur Aishah Mohd Taib Ali Ashrafzadeh Farhana Fadzli Faizah Harun Kartini Rahmat See Mee Hoong Puteri Shafinaz Abdul-Rahman Onn Haji Hashim 《PloS one》2016,11(2)
Heavily glycosylated mucin glycopeptides such as CA 27.29 and CA 15–3 are currently being used as biomarkers for detection and monitoring of breast cancer. However, they are not well detected at the early stages of the cancer. In the present study, perchloric acid (PCA) was used to enhance detection of mucin-type O-glycosylated proteins in the serum in an attempt to identify new biomarkers for early stage breast cancer. Sensitivity and specificity of an earlier developed sandwich enzyme-linked lectin assay were significantly improved with the use of serum PCA isolates. When a pilot case-control study was performed using the serum PCA isolates of normal participants (n = 105) and patients with stage 0 (n = 31) and stage I (n = 48) breast cancer, higher levels of total O-glycosylated proteins in sera of both groups of early stage breast cancer patients compared to the normal control women were demonstrated. Further analysis by gel-based proteomics detected significant inverse altered abundance of proteoglycan 4 and plasma protease C1 inhibitor in both the early stages of breast cancer patients compared to the controls. Our data suggests that the ratio of serum proteoglycan 4 to protease C1 inhibitor may be used for screening of early breast cancer although this requires further validation in clinically representative populations. 相似文献
980.